ATAD5 and colorectal carcinoma: As loss-of-function mutations in mammalian ATAD5 cause genomic instability and tumorigenesis, it is possible that low expression of BRCA1 in CRC correlates with worse outcomes due to co-occurring low expression of ATAD5.